23andMe (ME) Earnings Date, Estimates & Call Transcripts $0.94 -0.01 (-0.56%) (As of 12:33 PM ET) Add Compare Share Share Today's Range$0.93▼$0.9750-Day Range$0.71▼$1.0252-Week Range$0.61▼$3.14Volume749,574 shsAverage Volume2.58 million shsMarket Capitalization$452.71 millionP/E RatioN/ADividend YieldN/APrice Target$1.75 EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateFeb. 14EstimatedActual EPS (Nov. 8) -$0.16 Missed By -$0.16 Get 23andMe Earnings AlertsEnter your email address below to receive the latest news and earnings results for ME and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueME Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ME Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. ME Earnings Date and Information23andMe last issued its earnings data on November 8th, 2023. The reported ($0.16) EPS for the quarter. The company had revenue of $50 million for the quarter, compared to the consensus estimate of $56.80 million. 23andMe has generated ($0.73) earnings per share over the last year (($0.73) diluted earnings per share). 23andMe has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 14th, 2024 based off prior year's report dates.Read More 23andMe Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 2/14/2024Estimated)------- 11/8/2023Q2 2024-($0.16)($0.16)($0.16)$56.80 million$50.00 million8/8/2023Q1 2024-($0.22)($0.22)($0.21)$56.90 million$60.86 million5/25/2023Q4 2023($0.15)($0.14)+$0.01($0.14)$88.40 million$92.38 million 2/8/2023Q3 2023($0.19)($0.20)($0.01)($0.20)$65.90 million$67.00 million 11/7/2022Q2 2023-($0.15)($0.15)($0.15)$63.40 million$75.66 million8/8/2022Q1 2023-($0.20)($0.20)($0.20)$61.60 million$64.50 million Get the Latest News and Ratings for ME and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 23andMe and its competitors with MarketBeat's FREE daily newsletter. 5/26/2022Q4 2022-($0.13)($0.13)($0.10)$102.79 million$100.56 million 2/10/2022Q3 2022-($0.21)($0.21)($0.21)$54.30 million$56.89 million 11/9/2021Q3 2021($0.13)($0.04)+$0.09($0.04)-$55.20 million 8/13/2021Q2 2021($0.57)($0.25)+$0.32($0.25)-$59.24 million 23andMe Earnings - Frequently Asked Questions When is 23andMe's earnings date? 23andMe has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 14th, 2024 based off last year's report dates. Learn more on ME's earnings history. How much revenue does 23andMe generate each year? 23andMe (NASDAQ:ME) has a recorded annual revenue of $270.18 million. How much profit does 23andMe generate each year? 23andMe (NASDAQ:ME) has a recorded net income of -$311.66 million. ME has generated -$0.73 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Bicycle Therapeutics Earnings Lyell Immunopharma Earnings Phathom Pharmaceuticals Earnings Entrada Therapeutics Earnings LianBio Earnings ORIC Pharmaceuticals Earnings Aerovate Therapeutics Earnings Phibro Animal Health Earnings Liquidia Earnings ALX Oncology Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: The truth about Lululemon earnings: Suddenly in bearish crosshairOwn Dollar General? Hurry and take this advice before earningsEarnings propel Crowdstrike, cybersecurity sector, to new highsAlibaba is down more than 10% since earnings, now what?2 stocks that faded their price gaps after crushing earnings Hims & Hers earnings highlight expanded personalized treatmentsCan Kohl's keep its momentum after earnings dip? This page (NASDAQ:ME) was last updated on 12/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 23andMe Holding Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.